Clinical Trial Update: Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update indicates the termination of a Phase 2 study of pemetrexed in patients with chemosensitive and chemoresistant relapsed small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED